M. Davis

发表

Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout.

S. Wason, J. Digiacinto, Matthew W. Davis, 2013, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors.

R. Terkeltaub, D. Furst, J. Digiacinto, 2011, Arthritis and rheumatism.

Comparison of the Pharmacokinetics of Oxycodone Administered in Three Percocet® Formulations

A. Gammaitoni, M. Davis, Arnold R. Gammaitoni, 2002, Journal of clinical pharmacology.

Pharmacokinetics and Tolerability of Lidocaine Patch 5% with Extended Dosing

A. Gammaitoni, M. Davis, 2002, The Annals of pharmacotherapy.

Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.

R. Dworkin, A. Gammaitoni, Nathaniel Katz, 2002, Pain medicine.

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

R. Terkeltaub, D. Furst, Matthew W. Davis, 2010, Arthritis and rheumatism.

Effects of grapefruit and Seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects.

S. Wason, J. Digiacinto, Matthew W. Davis, 2012, Clinical therapeutics.

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials

M. Kaminer, J. Schlessinger, V. Young, 2022, Plastic and reconstructive surgery. Global open.

Effect of Steady-State Atorvastatin on the Pharmacokinetics of a Single Dose of Colchicine in Healthy Adults Under Fasted Conditions

S. Wason, M. Davis, 2014, Clinical Drug Investigation.

A new perspective on the pharmacoeconomics of colchicine

A. Wertheimer, T. Lauterio, Matthew W. Davis, 2011, Current medical research and opinion.

Clinically Significant Pharmacokinetic Interaction Between Colchicine and Ritonavir in Healthy Volunteers

S. Wason, J. Digiacinto, Matthew W. Davis, 2013 .

Effect of Cyclosporine on the Pharmacokinetics of Colchicine in Healthy Subjects

S. Wason, J. Digiacinto, Matthew W. Davis, 2012, Postgraduate medicine.

Erratum: Novel evidence‐based colchicine dose‐reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P‐glycoprotein inhibitors; Association of PPP2CA Polymorphisms With Systemic Lupus Erythematosus Susceptibility in Multiple Ethnic Groups

R. Terkeltaub, D. Furst, J. Digiacinto, 2011 .

Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.

J. Shavin, Jonathan Weiss, M. Davis, 2002, Clinical therapeutics.

Overall results of the BEST study following treatment of patients with mild to moderate acne.

J. Shavin, Jonathan Weiss, M. Davis, 2003, Cutis (New York, N.Y.).

The BEST study: evaluating efficacy by selected demographic subsets.

A. Fernández-Obregón, M. Davis, 2003, Cutis (New York, N.Y.).

Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.

J. Digiacinto, Matthew W. Davis, A.R. Godfrey, 2011, Clinical therapeutics.

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

R. Terkeltaub, D. Furst, K. Kook, 2010, Arthritis and rheumatism.

Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?

S. Wason, R. Faulkner, M. Davis, 2012, Advances in Therapy.